Elidel: Advanced Non-Steroidal Eczema Relief
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per tube | Price | Buy |
| 1 | $50.25 | $50.25 (0%) | 🛒 Add to cart |
| 2 | $45.23 | $100.51 $90.46 (10%) | 🛒 Add to cart |
| 3 | $40.20 | $150.76 $120.61 (20%) | 🛒 Add to cart |
| 4 | $37.69 | $201.01 $150.76 (25%) | 🛒 Add to cart |
| 5 | $34.17 | $251.27 $170.86 (32%) | 🛒 Add to cart |
| 6 | $30.15 | $301.52 $180.91 (40%) | 🛒 Add to cart |
| 7 | $27.28 | $351.78 $190.96 (46%) | 🛒 Add to cart |
| 8 | $25.13 | $402.03 $201.01 (50%) | 🛒 Add to cart |
| 9 | $23.45 | $452.28 $211.07 (53%) | 🛒 Add to cart |
| 10 | $22.11
Best per tube | $502.54 $221.12 (56%) | 🛒 Add to cart |
Synonyms | |||
Elidel (pimecrolimus) cream 1% is a topical immunomodulator specifically formulated for the management of mild to moderate atopic dermatitis, commonly known as eczema, in patients who are two years of age and older. It offers a targeted, steroid-free approach to controlling inflammation and itching, making it a suitable option for sensitive skin areas and long-term intermittent use. By modulating the immune response at the site of application, Elidel helps restore skin barrier function and reduce flare-ups, providing effective relief without the potential side effects associated with prolonged corticosteroid use. It is available by prescription and should be used under the guidance of a healthcare professional as part of a comprehensive eczema management plan.
Features
- Contains pimecrolimus 1% as the active ingredient
- White, homogeneous cream formulation for easy application
- Available in tubes of 30g, 60g, and 100g
- Non-greasy, fragrance-free base suitable for sensitive skin
- Designed for topical use only; not for ophthalmic, oral, or intravaginal use
- Requires storage at controlled room temperature (15°-30°C or 59°-86°F)
Benefits
- Provides rapid relief from itching and redness associated with eczema
- Reduces inflammation without the skin-thinning risks of corticosteroids
- Suitable for use on delicate areas including face, neck, and skin folds
- Supports long-term management with intermittent application
- Helps restore and maintain healthy skin barrier function
- Minimizes the frequency and severity of eczema flare-ups
Common use
Elidel cream is primarily prescribed for the treatment of mild to moderate atopic dermatitis in patients aged 2 years and older when conventional therapies are inadvisable or poorly tolerated. It is particularly beneficial for managing eczema in sensitive skin areas such as the face, eyelids, and neck where corticosteroid use may be concerning. Healthcare providers often recommend Elidel at the first signs of eczema symptoms to prevent full-blown flare-ups. The medication is typically used twice daily until symptoms clear, and may be employed as maintenance therapy with less frequent application to prolong remission periods between episodes.
Dosage and direction
Apply a thin layer of Elidel cream to affected areas twice daily, gently rubbing in until absorbed. Use the smallest amount needed to control symptoms. Treatment should begin at the first signs of eczema (redness, itching) and continue until complete clearance of symptoms. Do not apply under occlusive dressings unless directed by a physician. Wash hands after application unless treating hands. For patients aged 2-16 years, treatment should be limited to affected areas and used for the shortest duration necessary. Long-term continuous use beyond 6 weeks in children or 12 months in adults without reevaluation is not recommended.
Precautions
Avoid sunlight exposure, tanning beds, and phototherapy during treatment and for periods after discontinuation as directed by your physician. Use appropriate sun protection measures including protective clothing and broad-spectrum sunscreen. Do not apply to areas with active viral infections (e.g., herpes simplex, chickenpox). Monitor application sites for skin infections and discontinue use if infection develops. Use with caution in patients with Netherton’s syndrome or other skin barrier defects due to potential increased systemic absorption. Immunocompromised patients should use Elidel only under close medical supervision.
Contraindications
Hypersensitivity to pimecrolimus or any component of the formulation. Not recommended for use in patients with active cutaneous infections at treatment sites, including viral infections (herpes simplex, varicella zoster), fungal infections, or bacterial infections. Should not be used in patients with underlying immunosuppression, including those with HIV infection, lymphoma, or receiving immunosuppressive therapy. Contraindicated in patients with a history of malignant or premalignant skin conditions. Not indicated for use in children under 2 years of age.
Possible side effects
Most common side effects include application site reactions: burning sensation (up to 26% of patients), irritation, pruritus, and erythema. These typically occur during the first few days of treatment and usually diminish as the skin heals. Headache (5-12%) and increased cough or cold symptoms may occur. Less frequently reported effects include skin infections, folliculitis, acne, and herpes simplex reactivation. Rare cases of lymphadenopathy have been reported, though relationship to treatment is uncertain. Systemic absorption is minimal but possible, particularly with excessive application or compromised skin barrier.
Drug interaction
No formal drug interaction studies have been conducted with topical pimecrolimus. However, theoretically, concomitant use with other immunosuppressive agents could potentiate systemic immunosuppression. Use with CYP3A4 inhibitors (e.g., erythromycin, ketoconazole, calcium channel blockers) might increase pimecrolimus blood levels, though this is unlikely with topical application to intact skin. Avoid concurrent use with other topical preparations on the same skin area unless directed by a physician, as this may increase irritation or affect absorption.
Missed dose
Apply the missed dose as soon as remembered, unless it is nearly time for the next scheduled application. Do not apply double the amount to make up for a missed dose. Resume regular dosing schedule. If multiple doses are missed, contact your healthcare provider for guidance on resuming treatment. Consistent application is important for optimal efficacy, particularly during the initial treatment phase.
Overdose
Topical overdose is unlikely due to minimal systemic absorption when used as directed. Excessive application might increase the risk of local adverse effects such as intensified burning or irritation. Accidental ingestion requires immediate medical attention—symptoms may include gastrointestinal upset, headache, dizziness, or potential immunosuppressive effects. In case of ingestion, do not induce vomiting unless directed by poison control or medical personnel. Provide supportive care and monitor for signs of immunosuppression if large quantities were consumed.
Storage
Store at room temperature between 15°-30°C (59°-86°F). Do not freeze. Keep tube tightly closed when not in use. Protect from excessive heat and direct sunlight. Keep out of reach of children and pets. Do not use after expiration date printed on packaging. Discard any medication that has changed color, consistency, or shows signs of contamination. Do not transfer cream to other containers.
Disclaimer
This information is provided for educational purposes only and does not replace professional medical advice. Always consult with a qualified healthcare provider before starting, changing, or stopping any medication. Individual response to treatment may vary. Proper diagnosis and supervision are essential for safe and effective use. The prescribing physician should be informed of all medical conditions, current medications, and treatment response.
Reviews
Clinical studies demonstrate that Elidel provides significant improvement in eczema symptoms, with approximately 70% of patients achieving clear or almost clear skin after 6 weeks of treatment. Dermatologists frequently report satisfaction with its efficacy in sensitive areas and its steroid-sparing benefits. Patients appreciate the non-greasy texture and rapid relief from itching, though some note initial burning sensations that typically subside within several days. Long-term studies support its safety profile for intermittent use over periods up to one year in adults. Many clinicians consider it an valuable option in stepped treatment approaches for atopic dermatitis management.